By: Jordana G. Fein, MD, MS; Rishi P. Singh, MD
Eye care professionals may not know how to effectively identify patients in clinic who will benefit from Photodynamic Therapy (PDT), including those with persistent disease activity. This webinar includes discussions on real-world clinical scenarios in which the use of photodynamic therapy alone or in combination with anti-VEGFs can be a more efficacious treatment option than using anti-VEGFs alone, particularly in the setting of persistent disease activity.
TARGET AUDIENCE
This certified CME activity is designed for retina specialists and ophthalmologists involved in the management of retinal diseases.
This activity is supported by an educational grant from Bausch + Lomb.
Upon completion of this activity, participants will be better able to:
Provided by Evolve Medical Education
Accreditation Statement
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to obtain credit, complete the pretest, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+
Jordana G. Fein, MD, MS
Staff Physician, The Retina Group of Washington
Fairfax, Virginia
Rishi P. Singh, MD
Staff Physician, Cole Eye Institute
Medical Director, Clinical Systems Office Cleveland Clinic
Associate Professor of Ophthalmology, Case Western Reserve University
Cleveland, Ohio
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Jordana G. Fein, MD, MS, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Grant/Research Support: Apellis, Lexitas, Opthea, and Regeneron Pharmaceuticals. Speaker’s Bureau: Regeneron Pharmaceuticals.
Rishi P. Singh, MD, and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Bausch + Lomb, Genentech, Novartis, and Regeneron Pharmaceuticals. Grant/Research Support: Apellis and Graybug.
The Evolve staff and planners have no financial relationships with commercial interests.
Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.
In order to obtain credit, complete the pretest, proceed through the program, complete the post-test, evaluation and submit for credit.